EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C15H14N2O4S |
| Net Charge | 0 |
| Average Mass | 318.354 |
| Monoisotopic Mass | 318.06743 |
| SMILES | O=C(/C=C/c1cccc(S(=O)(=O)Nc2ccccc2)c1)NO |
| InChI | InChI=1S/C15H14N2O4S/c18-15(16-19)10-9-12-5-4-8-14(11-12)22(20,21)17-13-6-2-1-3-7-13/h1-11,17,19H,(H,16,18)/b10-9+ |
| InChIKey | NCNRHFGMJRPRSK-MDZDMXLPSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Role: | EC 3.5.1.98 (histone deacetylase) inhibitor An EC 3.5.1.* (non-peptide linear amide C-N hydrolase) inhibitor that interferes with the function of histone deacetylase (EC 3.5.1.98). |
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| belinostat (CHEBI:61076) has role antineoplastic agent (CHEBI:35610) |
| belinostat (CHEBI:61076) has role EC 3.5.1.98 (histone deacetylase) inhibitor (CHEBI:61115) |
| belinostat (CHEBI:61076) is a hydroxamic acid (CHEBI:24650) |
| belinostat (CHEBI:61076) is a olefinic compound (CHEBI:78840) |
| belinostat (CHEBI:61076) is a sulfonamide (CHEBI:35358) |
| IUPAC Name |
|---|
| (2E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide |
| INN | Source |
|---|---|
| belinostat | KEGG DRUG |
| Synonyms | Source |
|---|---|
| PXD101 | SUBMITTER |
| N-Hydroxy-3-(3-(phenylsulfamoyl)phenyl)prop-2-enamide | ChemIDplus |
| (2E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]acrylamide | IUPAC |
| Manual Xrefs | Databases |
|---|---|
| D08870 | KEGG DRUG |
| Belinostat | Wikipedia |
| Registry Numbers | Sources |
|---|---|
| Reaxys:10087570 | Reaxys |
| CAS:414864-00-9 | ChemIDplus |
| Citations |
|---|